There were 2,010 press releases posted in the last 24 hours and 438,731 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
FDA Approves Arcutis’ ZORYVE® (roflumilast) Cream 0.15% for the Treatment of Atopic Dermatitis in Adults and Children Down to 6 Years of Age

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image